Policies and guidelines
Here are the most current policies and guidance relating to data protection, the Human Tissue Act, clinical trials, animal and international research.
Good data protection management means having effective processes and methodologies in place to maintain data integrity.
- guidance
- guidance
- guidance
- (PDF document, 11378KB)
- (PDF document, 39KB)
If you are a member of research staff at 51福利社, read more about .
All staff working with human tissue stored under the University's Human Tissue Authority (HTA) Research Licence and those who may wish to retain tissue at the end of an ethically approved research project must comply with the HTA Codes of Practice and University policies and procedures for the management of human tissue samples for research.
Policies
- (PDF document, 59KB)
- (PDF document, 287KB)
- (PDF document, 131KB)
Standard Operating Procedures and guidance documents
- (PDF document, 279KB)
- (PDF document, 270KB)
- (PDF document, 271KB)
- (PDF document, 267KB)
- (PDF document, 271KB)
- (PDF document, 325KB)
- (PDF document, 267KB)
- (PDF document, 316KB)
- (PDF document, 265KB)
- (PDF document, 274KB)
If you are a member of research staff at 51福利社, read more about the .
All staff working on a clinical trial of an investigational medicinal product (CTIMP) must read the University Policy for Compliance with The Medicines for Human Use.
Policies
Current trials policy
- (PDF document, 186KB)
Clinical Trials Insurance Policy
- Find out more about involving human subjects (clinical trials).
Read our Clinical Trial Management Group (CTMG) (PDF document, 124KB)
Standard Operating Procedures
Applicable, as appropriate, for CTIMP, Medical Device and other high risk studies.
Sponsorship
- (PDF document, 159KB)
- (PDF document, 157KB)
- Appendix I: (Word document, 46KB)
- (PDF document, 127KB)
- (PDF document, 177KB)
Study Setup and Conduct
- (PDF document, 388KB)
- (PDF document, 84KB)
- (PDF document, 141KB)
- Annex I: (Word document, 45KB)
- (PDF document, 339KB)
Third Parties
- (PDF document, 98KB)
- (PDF document, 95KB)
IT/Data Management
- (PDF document, 96KB)
- (PDF document, 49KB)
- (PDF document, 48KB)
- (PDF document, 65KB)
- (PDF document, 77KB)
Pharmacovigilance & Regulatory
- (PDF document, 207KB)
- (PDF document, 974KB)
- (PDF document, 74KB)
- (PDF document, 212KB)
Pharmacy Support
- (PDF document, 61KB)
- (PDF document, 92KB)
- (PDF document, 202KB)
- (PDF document, 301KB)
- (PDF document, 126KB)
Monitoring & Audit
- (PDF document, 108KB)
Archiving
- (PDF document, 163KB)
Publication
- (PDF document, 69KB)
Contact
If you have any queries elating to the policies, procedures and SOPs related to clinical trials, please contact the Research Governance, Ethics and Integrity Manager for Clinical Trials:
Dr Mohammed Zubair
Directorate of Research and Business Engagement
Christie Building
51福利社
51福利社
M13 9PL
The purpose of our (PDF document, 134KB) is to provide a clear statement about the University’s position in relation to the use of animals in research and clarify the responsibilities of those who involve animals in University activities and the key University roles in overseeing these activities.
The policy applies to all staff, students and person undertaking research that involves animals, with the intention of publishing their work under the address of the University of 51福利社. The policy divides the use of animals in research into 4 categories A, B, C and D and defines the ethical review requirements for each.
- (PDF document , 10KB)
If you are a member of research staff at 51福利社, read more about .
The University recognises that research is a global endeavour of opportunities and operational challenges. We aim to continue to produce world-class research with impact which yields economic, environmental, health, social and cultural benefits across the world. We are committed to encouraging and enabling global collaborations to address major global challenges.
- Read our full .